Clinical Trial Update: Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

View source ↗

Summary

This ClinicalTrials.gov entry reports a post-market clinical follow-up study of the Axonics R20 sacral neuromodulation device for fecal incontinence, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fecal Incontinence

Drugs mentioned

• Axonics R20

Snippet

Sponsor: Axonics, Inc. | Conditions: Fecal Incontinence | Status: NOT_YET_RECRUITING